Gene Query: SYNJ2BP

Dataset Description Geneva Score
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 32.87
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 27.82
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 27.25
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 26.4
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 25.45
Studying the selectivity of a small molecule Synucleozid on transcriptome 24.94
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 24.23
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 21.46
Genome wide expression change by RNF168 knocking down in MCF-7 cells 21.17
The regulartory role of ZCCHC24 in splicing machinery 19.95
MYCi975 regulates MYC target genes 19.86
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 19.51
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 19.51
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 18.95
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 18.23
Transcriptome analysis of Zika infected neural stem cells 18.06
Zika infected neural stem cells 18.06
Genome-wide analysis of the Integrator complex 16.84
Genome-wide analysis of the Integrator complex (HTS) 16.84
ChIP-seq and RNA-seq from human lymphoma cell lines 16.82
RNA-seq data from human lymphoma cell lines 16.82
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 16.66
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 16.38
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 16.38
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 16.11
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 15.74
Cell responses to dysregulated VZV-induced cell-cell fusion 15.02
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 14.87
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 14.87
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 14.75
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 14.55
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 14.39
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 14.39
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 14.13
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 13.55
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 13.55
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 13.42
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 13.25
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 13.24
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 12.9
RNAseq analysis of ESRP regulated splicing events in prostate cancer 12.82
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 12.62
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 12.62
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 12.42
Human HAP1 cells before and after nutrient deprivation 12.4
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 12.4
RNA-Seq with and without RNase treatment in PCa cell lines 12.25
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 12.09
Gene expression analysis of immortalized human liver progenitor-like cells in culture 12.03
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 11.71
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 11.5
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 11.44
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 11.38
Identification of global XBP1s target gene expression in human prostate cancer cells 10.98
Genome wide expression change in LCC2 and MCF-7 cells 10.85
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 10.81
RNA-seq of tumor cells following angiopellosis extravasation 10.7
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 10.64
Transcriptomic analyssis following EHMT1/2 inhibition 10.59
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 10.52
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 10.51
RNA-seq of YB5 cells treated with Proscillaridin A 10.38
Patient-derived luminal breast cancer xenografts with progestins 10.35
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 10.35
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 10.27
LNCaP treated with iBET 10.17
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 10.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 10.02
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 9.97
Effect of CHKA knockdown on C4-2 cell transcriptome 9.94
Tracking of dCas9-methyltransferase footprints 9.8
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 9.71
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 9.65
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 9.5
BAF controls genome accessibility 9.44
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.32
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 9.31
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.29
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.28
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 9.23
Systematic discovery of endogenous human ribonucleoprotein complexes 9.21
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 9.12
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 9.05
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 9.0
Proliferation-correlated expression 8.93
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 8.81
ARID1A regulates condensin II distribution and chromosomal partition 8.81
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 8.56
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 8.54
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 8.48
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.17
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.16
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 8.12
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.11
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.1
IRF2 is a master regulator of human keratinocyte stem cell fate 8.1
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.08
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.08
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.08
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.06
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.02
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.95
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 7.87
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.81
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.77
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.77
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.75
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 7.73
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 7.66
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 7.66
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.65
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.64
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.6
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.55
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.55
TGF-β regulation of miRNA expression in pancreatic cancer 7.53
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 7.52
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.49
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.47
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.47
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 7.46
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.42
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 7.42
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 7.41
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.41
Genome wide expression change by RNF168 knocking down in NEC cells 7.38
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 7.35
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 7.35
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 7.35
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.28
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.27
Human cell line and subcutaneous tumor 7.24
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 7.22
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.18
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.16
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.15
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 7.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 7.14
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.14
Gene expression in PANC1 cells treated with Rakicidin 7.08
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.05
RNAseq Study in CC-671 Treated Cal-51 Cells 7.05
Lipid degradation promotes prostate cancer cell survival 6.85
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.84
STX4 Over-Expression in Human islets 6.82
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.79
Global Mapping of Human RNA-RNA Interactions 6.79
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.76
Gene expression regulated by CSA and CSB in neuroblastoma cell line 6.69
snRNAs as regulators of alternative splicing 6.66
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 6.65
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.64
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.58
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.57
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.57
Downregulation of DDX5/DDX17 and REST 6.57
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.55
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.55
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.55
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 6.52
Differentiation enhances Zika virus infection in neuronal brain cells 6.51
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.5
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.5
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 6.49
RNA-seq differential expression studies: more sequence, or more replication? 6.48
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.48
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 6.46
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.43
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 6.42
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.42
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.41
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 6.36
Accurate annotation of human protein-coding small open reading frames 6.34
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.34
Global gene expression profile of dasatinib-resistant RCH-ACV cells 6.33
The cohesin release factor WAPL restricts chromatin loop extension. 6.27
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.22
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.2
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.19
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.19
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.18
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.14
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 6.12
Functional role of SLIT2 and ROBO1 in trophoblasts 6.1
scRNASeq analysis of cycling cardiomyocytes 6.1
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.1
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.09
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.09
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 6.07
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.99
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 5.96
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 5.95
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 5.9
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 5.9
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 5.89
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 5.86
Argonaute proteins couple chromatin silencing to alternative splicing 5.86
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.85
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.85
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.85
Region-specific Innate Antiviral Responses of the Human Epididymis 5.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.83
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 5.82
RNA seq comparison between scrambled and shGRP78 cells 5.79
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.79
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 5.77
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 5.77
mRNA expression in human DAOY cells 5.76
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 5.75
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 5.75
Genome-wide functional assessment of enhancer activities in the human genome 5.75
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.69
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.63
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.62
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.62
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.57
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.57
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 5.56
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 5.55
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.54
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 5.54
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.52
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.51
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 5.51
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.5
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.49
A549 cells and MSR-A549 cells 5.48
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.48
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.44
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 5.37
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.36
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.36
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 5.34
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.33
Transcriptional effect of ETV1 knockdown in melanoma cells 5.33
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 5.23
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.23
MYC dependent mRNA translation shapes gene expression and cell biology 5.22
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 5.22
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 5.22
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 5.22
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 5.21
Expression profiling of etoposide-induced senescent cells 5.21
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 5.21
Loss of endometrial plasticity in recurrent pregnancy loss 5.21
Electronic cigarettes 5.19
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.17
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.16
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.15
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.14
FOXP1 orchestration of ASD-relevant signaling pathways. 5.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.05
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.04
Single-Cell Genotyping of Transcriptomes 5.03
RNA-seq of Single-Cell Genotyping of Transcriptomes 5.03
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.0
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.0
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.99
Determination of tRNA aminoacylation levels by high throughput sequencing 4.97
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.94
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.94
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 4.93
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.92
Human embryonic stem cells in E8 and AKIT culture medium 4.92
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.91
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.89
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.89
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.87
Transcriptional profiling of LS1034 cells treated with tepoxalin 4.87
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.87
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.85
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 4.82
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 4.82
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.81
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.81
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.81
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.79
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.75
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.73
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.71
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.68
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.68
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.68
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.64
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.64
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.61
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 4.6
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 4.6
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.59
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.57
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 4.54
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.52
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.52
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.52
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 4.5
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.49
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.48
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.45
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.4
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 4.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.36
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.25
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 4.25
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.24
Direct Isolation and Characterization of Human Nephron Progenitors. 4.22
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 4.18
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.18
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.16
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.14
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.13
Transcriptomic analysis of LSD1 4.12
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.09
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.08
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 4.05
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 4.03
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.95
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.92
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.88
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.86
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.85
Transcriptome-wide response to synthetic chromatin protein PcTF 3.85
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.83
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.78
N6-methyladenine DNA Modification in Glioblastoma 3.78
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.74
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
Gene expression in GBM with Cav3.2 inhibition 3.67
Gene expression profile in breast cancer cells 3.63
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.63
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.62
Cajal bodies are linked to genome conformation 3.52
Cajal bodies are linked to genome conformation [RNA-Seq] 3.52
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.51
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.51
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.49
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 3.49
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.47
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.45
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.32
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.32
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 3.3
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 3.3
mRNA-Seq profiling of human developing kidney 3.27
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.23
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.23
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.23
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.14
Differential responses of human fetal brain neural stem cells to Zika virus infection 3.12
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.12
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.11
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.08
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.04
RNA Sequencing of Human iPS derived Cardiomyocytes 3.03
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.01
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.99
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.99
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.9
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 2.86
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.85
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.79
Changes in human endometrial gland transcriptome over the window of implantation 2.75
Interaction between mitoNEET and NAF-1 in cancer cells 2.71
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.7
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.7
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 2.64
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.64
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.63
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.57
CDK12 mediated transcriptional regulation in U2OS cells 2.55
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.54
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.51
SRSF1 role in cellular gene expression and splicing 2.44
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.42
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.41
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.35
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.34
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.34
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.23
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.23
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.16
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.12
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.1
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.08
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.03
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.01
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.0
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.98
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.98
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.97
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.97
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.96
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.96
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.95
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.93
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.93
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.91
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.87
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.84
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.84
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.8
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.77
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.75
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.74
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.72
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.72
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.71
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.67
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.64
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.63
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.59
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.58
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.55
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.51
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.5
Dilated cardiomyopathy vs Myocarditis 1.5
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.49
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.49
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.47
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.47
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.46
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.44
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.44
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.44
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.43
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.43
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.42
Gene expression analysis upon mtDNA depletion 1.42
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.42
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.41
Epigenomic conservation of transposable element silencing 1.4
Epigenomic conservation of transposable element silencing [RNA-seq] 1.4
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.36
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 1.34
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.34
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.31
Functional role of CPPED1 in trophoblasts. 1.31
Transposon-based construction of strand-specific RNA-seq libraries 1.31
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.21
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.2
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.16
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.14
MCF-7 as a model for functional analysis of breast cancer risk variants 1.12
RNA-seq data 1.06
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.04
Gene expression of collecting duct carcinoma of the kidney 1.01
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.93
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.89
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.87
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.87
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.87
Transcriptome-wide modulation of splicing by the exon junction complex 0.82
Molecular analysis of renal cell carcinoma with unclassfied histology 0.8
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.8
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.78
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.76
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.74
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.73
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.72
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.69
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.65
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.64
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.62
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.62
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.59
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.58
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.53
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.5
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.45
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.43
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.43
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.43
High-resolution comparative analysis of great ape genomes 0.42
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.41
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.39
Function and hormonal regulation of GATA3 in human first trimester placentation 0.35
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.2
p53 activity results in DNA replication fork processivity 0.15
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.15
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.15
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.15
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.15
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.14
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.14
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.13
Modulation of nonsense-mediated decay by rapamycin 0.11
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.08
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.01
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.0
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation